Pfizer revenues to slow as drugs lose exclusivity

American pharmaceutical company Pfizer warned investors of little revenue growth to come in 2019, owing partly to expiring exclusivity rights on drugs including Viagra and the seizure medicine Lyrica.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Pfizer allows Teva’s generic Viagra

19 December 2013 Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.

Americas

Pfizer expects $1.9bn loss due to patent expirations

31 July 2018 US-based pharmaceutical company Pfizer today reported an increase in year-on-year revenue for the second quarter but projected nearly a $2 billion loss in 2018 due to patent expirations.

Americas

FDA opens US to Lyrica generics

24 July 2019 The US Food and Drug Administration last week approved nine applications for the first generic versions of Pfizer’s Lyrica.

More on this story

Americas

Pfizer allows Teva’s generic Viagra

19 December 2013 Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.

Americas

Pfizer expects $1.9bn loss due to patent expirations

31 July 2018 US-based pharmaceutical company Pfizer today reported an increase in year-on-year revenue for the second quarter but projected nearly a $2 billion loss in 2018 due to patent expirations.

Americas

FDA opens US to Lyrica generics

24 July 2019 The US Food and Drug Administration last week approved nine applications for the first generic versions of Pfizer’s Lyrica.

More on this story

Americas

Pfizer allows Teva’s generic Viagra

19 December 2013 Viagra-maker Pfizer Ltd and Teva Pharmaceutical Industries have agreed to settle patent litigation related to Teva’s generic version of Viagra (sildenafil citrate) tablets.

Americas

Pfizer expects $1.9bn loss due to patent expirations

31 July 2018 US-based pharmaceutical company Pfizer today reported an increase in year-on-year revenue for the second quarter but projected nearly a $2 billion loss in 2018 due to patent expirations.

Americas

FDA opens US to Lyrica generics

24 July 2019 The US Food and Drug Administration last week approved nine applications for the first generic versions of Pfizer’s Lyrica.